scholarly article | Q13442814 |
P2093 | author name string | Dirk Bumann | |
Helmut Bloecker | |||
Holger Loessner | |||
Igor V Deyneko | |||
Kathrin Wolf | |||
Sara Leschner | |||
Siegfried Weiss | |||
Stefan Lienenklaus | |||
P2860 | cites work | EcoCyc: a comprehensive database of Escherichia coli biology | Q24612081 |
Quantifying similarity between motifs | Q27499384 | ||
Fitting a mixture model by expectation maximization to discover motifs in biopolymers | Q27860556 | ||
WebLogo: A Sequence Logo Generator | Q27860646 | ||
Examination of Salmonella gene expression in an infected mammalian host using the green fluorescent protein and two-colour flow cytometry | Q30828698 | ||
Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma | Q33340438 | ||
Salmonella promoters preferentially activated inside tumors | Q33344346 | ||
Tumor invasion of Salmonella enterica serovar Typhimurium is accompanied by strong hemorrhage promoted by TNF-alpha | Q33495169 | ||
Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium | Q33756746 | ||
Vessel destruction by tumor-targeting Salmonella typhimurium A1-R is enhanced by high tumor vascularity | Q34620886 | ||
Drug resistance and cellular adaptation to tumor acidic pH microenvironment | Q35592647 | ||
Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer | Q35840470 | ||
The use of clostridial spores for cancer treatment. | Q36565145 | ||
Host-microbe communication within the GI tract. | Q37289355 | ||
Salmonella-allies in the fight against cancer | Q37762990 | ||
Modulation of natural immunity in the gut by Escherichia coli strain Nissle 1917. | Q37774424 | ||
Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines | Q39513114 | ||
Remote control of tumour-targeted Salmonella enterica serovar Typhimurium by the use of L-arabinose as inducer of bacterial gene expression in vivo | Q40171422 | ||
Systemic administration of an attenuated, tumor-targeting Salmonella typhimurium to dogs with spontaneous neoplasia: phase I evaluation | Q40504400 | ||
Continuous intravenous administration of live genetically modified salmonella typhimurium in patients with metastatic melanoma | Q43161957 | ||
Targeted therapy with a Salmonella typhimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude mice | Q43677697 | ||
Biofilm formation by Salmonella enterica serovar Typhimurium colonizing solid tumours | Q50042401 | ||
From spinach scare to cancer care | Q50043261 | ||
Containment of tumor-colonizing bacteria by host neutrophils | Q50062621 | ||
Identification of host-induced pathogen genes by differential fluorescence induction reporter systems | Q50072446 | ||
Sparse initial entrapment of systemically injected Salmonella typhimurium leads to heterogeneous accumulation within tumors | Q50102730 | ||
Tumor-targeted Salmonella as a novel anticancer vector | Q50133173 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Salmonella Typhimurium | Q166491 |
P304 | page(s) | 2984-2994 | |
P577 | publication date | 2011-12-02 | |
P1433 | published in | Nucleic Acids Research | Q135122 |
P1476 | title | Identification of tumor-specific Salmonella Typhimurium promoters and their regulatory logic | |
P478 | volume | 40 |
Q34315760 | A bioluminescent transposon reporter-trap identifies tumor-specific microenvironment-induced promoters in Salmonella for conditional bacterial-based tumor therapy |
Q64124307 | Advances in bacterial cancer therapies using synthetic biology |
Q34381649 | An integrative computational approach to effectively guide experimental identification of regulatory elements in promoters |
Q26751222 | Bacteria in Cancer Therapy: Renaissance of an Old Concept |
Q37718566 | Bacterial Carriers for Glioblastoma Therapy |
Q90716178 | Bacterial delivery of the anti-tumor azurin-like protein Laz to glioblastoma cells |
Q37231785 | Candidate SNP Markers of Chronopathologies Are Predicted by a Significant Change in the Affinity of TATA-Binding Protein for Human Gene Promoters. |
Q36760451 | Candidate SNP Markers of Gender-Biased Autoimmune Complications of Monogenic Diseases Are Predicted by a Significant Change in the Affinity of TATA-Binding Protein for Human Gene Promoters |
Q36255004 | Candidate SNP markers of aggressiveness-related complications and comorbidities of genetic diseases are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters. |
Q54936700 | Candidate SNP markers of reproductive potential are predicted by a significant change in the affinity of TATA-binding protein for human gene promoters. |
Q36015577 | Composing a Tumor Specific Bacterial Promoter |
Q90777022 | Genetic circuit design automation for the gut resident species Bacteroides thetaiotaomicron |
Q96126440 | Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity |
Q40163572 | Local application of bacteria improves safety of Salmonella -mediated tumor therapy and retains advantages of systemic infection. |
Q38203911 | Murine solid tumours as a novel model to study bacterial biofilm formation in vivo |
Q64241311 | Natural Selection Equally Supports the Human Tendencies in Subordination and Domination: A Genome-Wide Study With Confirmation and Validation in Mice |
Q35875387 | Obesity-related known and candidate SNP markers can significantly change affinity of TATA-binding protein for human gene promoters |
Q38391065 | Phenotypic evolution of therapeutic Salmonella enterica serovar Typhimurium after invasion of TRAMP mouse prostate tumor |
Q26996526 | Salmonella enterica serovars Typhimurium and Typhi as model organisms: revealing paradigm of host-pathogen interactions |
Q39339432 | Salmonella-Mediated Cancer Therapy: Roles and Potential |
Q37225613 | Therapy of solid tumors using probiotic Symbioflor-2: restraints and potential |
Q58599910 | Tumour-targeting bacteria engineered to fight cancer |
Search more.